Spray Nasal Good news for the children terrified of needles. The High Council of Public Health (CUSP) has issued a marketing authorization for a vaccine against the flu is administered nasally. It will, however, have to wait due to some packaging problems Spray Nasal.
Experts of the High Council of Public Health (CUSP) gave the green light to Flue ® influenza vaccine during the revision of the immunization schedule. This type of vaccine, which is administered by nasal passages "Spray Nasal", was used in the United States since 2003. This vaccine, according to the Institute of Health Surveillance is intended to fill the gap vaccine in children at risk. Indeed, clinical studies have shown that this type of vaccine was more effective than conventional vaccines younger. The influenza vaccine is an attenuated unlike conventional vaccines are inactivated vaccines vaccine. "Spray Nasal" Its effectiveness in younger reached 80% against 50% for conventional influenza vaccines administered by injection. This vaccine is intended primarily for children 2-17 years of age who suffer from chronic diseases and as well as malformations of the respiratory tract and respiratory failure. Vaccination in these patients is recommended at the age of 6 months "Spray Nasal".
"Spray Nasal" The French health authorities have announced the availability of the vaccine for next fall, but it will take a little longer. Jean-Yves Mare spokesman laboratory Straitened (company that markets the vaccine Flue ® "Spray Nasal"), announced that the deadline could not be met. The cause: a packaging problem. In the United States, box of 10 doses of vaccine is delivered to physicians who take care of the flow unit. In France, such a packaging does not hold, since the legislation has given the exclusive right to sell drugs to pharmacists. "Spray Nasal" In addition, pharmacists are not allowed to open the boxes of drugs for retail sale. Another problem is the time it takes to order a vaccine. In fact, the vaccine must be ordered well in advance. These two problems taken together, prohibit the availability of the vaccine for the fall of 2012. It will at least wait until the fall of 2013. The vaccine works on mucosal immunity and causes similar to those of influenza reactions. It is not recommended for children under 2 years, pregnant women and people with immune suppression. And people under chemotherapy, people waiting for a transplant and those subjected to treatment against rejection after a transplant should not use it "Spray Nasal".